Centre Hospitalier La Chartreuse, 21000 Dijon, France.
CHU Dijon Bourgogne, Université Bourgogne Franche-Comté, Bourgogne Franche-Comté, France.
Encephale. 2023 Oct;49(5):525-531. doi: 10.1016/j.encep.2023.01.008. Epub 2023 Mar 31.
Nightmares can be defined as "an unpleasant dream with anxiety and oppression". They represent a symptom possibly leading to serious psychiatric and physical consequences. It occurs to 2% to 8% of the general population. Lucid dreaming therapy (LDT) is an interesting upcoming psychotherapy for the treatment of nightmares. The aim of this study was to evaluate the efficacy of LDT in the treatment of nightmares in adults and children.
We performed a systematic review of the literature, based on the Cochrane organisation's methodology. We explored the PubMed, Cochrane library, PsycINFO via Ovid and Embase databases and clinical trial registries (CTR), namely clinicaltrials.gov, EU clinical trials and the WHO clinical trials registry platform.
Four randomized controlled trials (RCT), 2 case series and 5 case reports were included. Most of the included studies found LDT effective in reducing nightmare frequency among adults with chronic and recurring nightmares. We did not identify any reports in children.
Despite a limited internal validity for the included studies, these first results are encouraging. Nonetheless, larger and more rigorous studies would allow to better assess the utility of LDT for nightmares.
噩梦可以被定义为“带有焦虑和压抑感的不愉快的梦”。它们代表了一种可能导致严重精神和身体后果的症状。它发生在 2%至 8%的普通人群中。清醒梦疗法（LDT）是一种很有前途的治疗噩梦的心理治疗方法。本研究的目的是评估 LDT 在治疗成人和儿童噩梦方面的疗效。
我们按照 Cochrane 组织的方法进行了系统的文献回顾。我们检索了 PubMed、Cochrane 图书馆、通过 Ovid 检索的 PsycINFO 和 Embase 数据库以及临床试验注册处（CTR），包括 clinicaltrials.gov、EU 临床试验和世界卫生组织临床试验注册平台。
共纳入 4 项随机对照试验（RCT）、2 项病例系列研究和 5 项病例报告。大多数纳入的研究发现 LDT 对治疗慢性和反复发作的成人噩梦有效，可以降低噩梦的频率。我们没有在儿童中发现任何报告。
尽管纳入的研究内部有效性有限，但这些初步结果令人鼓舞。然而，更大和更严格的研究将能够更好地评估 LDT 在治疗噩梦方面的效用。
